Keywords: merck, drops, hiv, vacc, candidate, fails, demonstrate

Merck drops HIV vacc candidate as it fails to demonstrate efficacy in DSBM review

Article | 01 October 2007

Print This

US drug major Merck & Co says it has discontinued development of its investigational HIV vaccine candidate V520, after it failed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in